Luteolin Alleviates the TNF‐ α ‐Induced Inflammatory Response of Human Microvascular Endothelial Cells via the Akt/MAPK/NF‐ κ B Pathway
Mediators of Inflammation · 2024
DOI: 10.1155/mi/6393872 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mediators of Inflammation, 2024. Verfasst von Qing-Yu Lu und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China. Hauptthemen laut MEDLINE: Luteolin, Tumor Necrosis Factor-alpha, Proto-Oncogene Proteins c-akt, Endothelial Cells. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Endothelial dysfunction and pathological alterations are pivotal in the pathogenesis of cardiovascular disease. To date, effective interventions for these endothelial changes are lacking. Tumor necrosis factor‐alpha (TNF‐ α ) is known to significantly contribute to these alterations. It has been reported the potential of luteolin to mitigate TNF‐ α ‐induced inflammation, yet its specific mechanisms and targets still remain to be elucidated. This study aims to investigate the effects and mechanisms of luteolin on TNF‐ α ‐induced inflammatory injury in human microvascular endothelial cells, thereby advancing the understanding of luteolin’s medicinal properties. Our findings demonstrate that luteolin notably inhibits TNF‐ α ‐induced phosphorylation of Akt, mitogen activated protein kinase (MAPK), and the nuclear factor‐kappaB (NF‐ κ B) p65. It significantly reduces the transcriptional activity of NF‐ κ B p65 and AP‐1 and decreases the expression of mRNA and proteins related to adhesion molecules and inflammatory mediators. Additionally, luteolin inhibited the reduction in STAT3 phosphorylation. In conclusion, luteolin effectively suppresses TNF‐ α ‐induced inflammatory injury in endothelial cells via the Akt/MAPK/NF‐ κ B pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China.
- Institute of Pharmacology and Bioactivity, Natural Products Research Center of Guizhou Province, Guiyang 550014, China.
ORCID-Profile: Qing-Yu Lu, Qian-Yun Sun
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Lu, Q. Y., Guo, L., Zhang, Q. Y., Yang, F. M., Zhou, S. T., & Sun, Q. Y. (2024). Luteolin Alleviates the TNF‐ α ‐Induced Inflammatory Response of Human Microvascular Endothelial Cells via the Akt/MAPK/NF‐ κ B Pathway. Mediators of Inflammation. https://doi.org/10.1155/mi/6393872
Vancouver
Lu QY, Guo L, Zhang QY, Yang FM, Zhou ST, Sun QY. Luteolin Alleviates the TNF‐ α ‐Induced Inflammatory Response of Human Microvascular Endothelial Cells via the Akt/MAPK/NF‐ κ B Pathway. Mediators of Inflammation. 2024. doi:10.1155/mi/6393872
BibTeX
@article{Lu2024,
author = {Lu, Qing-Yu and Guo, Li and Zhang, Qi-Yun and Yang, Fu-Mei and Zhou, Shu-Ting and Sun, Qian-Yun},
title = {Luteolin Alleviates the TNF‐ α ‐Induced Inflammatory Response of Human Microvascular Endothelial Cells via the Akt/MAPK/NF‐ κ B Pathway},
journal = {Mediators of Inflammation},
year = {2024},
doi = {10.1155/mi/6393872}
}
EUVIMED